Bunnage Mark E. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$930,529.03

Insider Activity of Bunnage Mark E.

According to the SEC Form 4 filings, Bunnage Mark E., being in a position of

  1. EVP, Chief Scientific Officer at Vertex Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 6293 shares for $3M,
    over all time since 2026-02-11, has bought 0 shares, and sold 6293 shares for $3M.

Biography of Bunnage Mark E.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,999,7345100

Comparison of Insiders on Amount of Buys and Sells

2026-05-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Scientific Officer
33
<0.0001%
$453.45$14,964+15.07%
2026-02-25SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Scientific Officer
620
0.0002%
$486.35$301,537-0.6%
2026-02-18SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Scientific Officer
1,182
0.0005%
$473.68$559,890+2.1%
2026-02-17SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Scientific Officer
2,437
0.001%
$489.46$1.19M+0.59%
2026-02-11SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Scientific Officer
2,021
0.0008%
$460.43$930,529+4.1%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.